218 related articles for article (PubMed ID: 37242599)
41. Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood-brain barrier injury through the Wnt/β-catenin signalling pathway.
Chen XY; Wan SF; Yao NN; Lin ZJ; Mao YG; Yu XH; Wang YZ
Mil Med Res; 2021 Dec; 8(1):62. PubMed ID: 34857032
[TBL] [Abstract][Full Text] [Related]
42. The pivotal role of micro-environmental cells in a human blood-brain barrier in vitro model of cerebral ischemia: functional and transcriptomic analysis.
Gerhartl A; Pracser N; Vladetic A; Hendrikx S; Friedl HP; Neuhaus W
Fluids Barriers CNS; 2020 Mar; 17(1):19. PubMed ID: 32138745
[TBL] [Abstract][Full Text] [Related]
43. Sitagliptin attenuates metformin-mediated AMPK phosphorylation through inhibition of organic cation transporters.
Choi MK; Jin QR; Ahn SH; Bae MA; Song IS
Xenobiotica; 2010 Dec; 40(12):817-25. PubMed ID: 20863201
[TBL] [Abstract][Full Text] [Related]
44. URB597 and Andrographolide Improve Brain Microvascular Endothelial Cell Permeability and Apoptosis by Reducing Oxidative Stress and Inflammation Associated with Activation of Nrf2 Signaling in Oxygen-Glucose Deprivation.
Wang DP; Kang K; Sun J; Lin Q; Lv QL; Hai J
Oxid Med Cell Longev; 2022; 2022():4139330. PubMed ID: 35602108
[TBL] [Abstract][Full Text] [Related]
45. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
Nies AT; Koepsell H; Damme K; Schwab M
Handb Exp Pharmacol; 2011; (201):105-67. PubMed ID: 21103969
[TBL] [Abstract][Full Text] [Related]
46. Mechanistic in vitro studies confirm that inhibition of the renal apical efflux transporter multidrug and toxin extrusion (MATE) 1, and not altered absorption, underlies the increased metformin exposure observed in clinical interactions with cimetidine, trimethoprim or pyrimethamine.
Elsby R; Chidlaw S; Outteridge S; Pickering S; Radcliffe A; Sullivan R; Jones H; Butler P
Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971610
[TBL] [Abstract][Full Text] [Related]
47. A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation.
Vemula S; Roder KE; Yang T; Bhat GJ; Thekkumkara TJ; Abbruscato TJ
J Pharmacol Exp Ther; 2009 Feb; 328(2):487-95. PubMed ID: 18981287
[TBL] [Abstract][Full Text] [Related]
48. Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations.
König J; Zolk O; Singer K; Hoffmann C; Fromm MF
Br J Pharmacol; 2011 Jun; 163(3):546-55. PubMed ID: 20883471
[TBL] [Abstract][Full Text] [Related]
49. Update on drug-drug interaction at organic cation transporters: mechanisms, clinical impact, and proposal for advanced
Koepsell H
Expert Opin Drug Metab Toxicol; 2021 Jun; 17(6):635-653. PubMed ID: 33896325
[No Abstract] [Full Text] [Related]
50. Autophagy-mediated occludin degradation contributes to blood-brain barrier disruption during ischemia in bEnd.3 brain endothelial cells and rat ischemic stroke models.
Kim KA; Kim D; Kim JH; Shin YJ; Kim ES; Akram M; Kim EH; Majid A; Baek SH; Bae ON
Fluids Barriers CNS; 2020 Mar; 17(1):21. PubMed ID: 32169114
[TBL] [Abstract][Full Text] [Related]
51. Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions.
Roux F; Couraud PO
Cell Mol Neurobiol; 2005 Feb; 25(1):41-58. PubMed ID: 15962508
[TBL] [Abstract][Full Text] [Related]
52. Characterization of the inhibitory effects of N-butylpyridinium chloride and structurally related ionic liquids on organic cation transporters 1/2 and human toxic extrusion transporters 1/2-k in vitro and in vivo.
Cheng Y; Martinez-Guerrero LJ; Wright SH; Kuester RK; Hooth MJ; Sipes IG
Drug Metab Dispos; 2011 Sep; 39(9):1755-61. PubMed ID: 21646436
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of Systemic and Brain Pharmacokinetic Parameters for Repurposing Metformin Using Intravenous Bolus Administration.
Sharma S; Zhang Y; Patel D; Akter KA; Bagchi S; Sifat AE; Nozohouri E; Ahn Y; Karamyan VT; Bickel U; Abbruscato TJ
J Pharmacol Exp Ther; 2024 May; ():. PubMed ID: 38777603
[TBL] [Abstract][Full Text] [Related]
54. Sirt1-Sirt3 axis regulates human blood-brain barrier permeability in response to ischemia.
Chen T; Dai SH; Li X; Luo P; Zhu J; Wang YH; Fei Z; Jiang XF
Redox Biol; 2018 Apr; 14():229-236. PubMed ID: 28965081
[TBL] [Abstract][Full Text] [Related]
55.
Hu S; Wu Y; Zhao B; Hu H; Zhu B; Sun Z; Li P; Du S
Molecules; 2018 Oct; 23(11):. PubMed ID: 30373188
[TBL] [Abstract][Full Text] [Related]
56. An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1.
Helms HC; Hersom M; Kuhlmann LB; Badolo L; Nielsen CU; Brodin B
AAPS J; 2014 Sep; 16(5):1046-55. PubMed ID: 24934296
[TBL] [Abstract][Full Text] [Related]
57. Dexamethasone regulation of P-glycoprotein activity in an immortalized rat brain endothelial cell line, GPNT.
Régina A; Romero IA; Greenwood J; Adamson P; Bourre JM; Couraud PO; Roux F
J Neurochem; 1999 Nov; 73(5):1954-63. PubMed ID: 10537053
[TBL] [Abstract][Full Text] [Related]
58. bFGF Protects Against Oxygen Glucose Deprivation/Reoxygenation-Induced Endothelial Monolayer Permeability via S1PR1-Dependent Mechanisms.
Lin L; Wang Q; Qian K; Cao Z; Xiao J; Wang X; Li X; Yu Z
Mol Neurobiol; 2018 Apr; 55(4):3131-3142. PubMed ID: 28466272
[TBL] [Abstract][Full Text] [Related]
59. Neutrophils block permeability increases induced by oxygen glucose deprivation in a culture model of the human blood-brain barrier.
Cowan KM; Easton AS
Brain Res; 2010 May; 1332():20-31. PubMed ID: 20346925
[TBL] [Abstract][Full Text] [Related]
60. Modulation of P-glycoprotein in rat brain microvessel endothelial cells under oxygen glucose deprivation.
Ji BS; Cen J; He L; Liu M; Liu YQ; Liu L
J Pharm Pharmacol; 2013 Oct; 65(10):1508-17. PubMed ID: 24028618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
